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Abstract 
In 1997 Valkó et al. developed a generic fast gradient HPLC method, based on the calculation of the 
Chromatographic Hydrophobicity Index (CHI) from the gradient retention times, in order to measure 
lipophilicity. We have employed the correlations between CHI and log Po/w and adapted the rapid gradient 
HPLC method to UHPLC obtaining excellent resolution and repeatability in a short analysis time (< 4min). 
log Po/w values can be easily obtained from these CHI measurements but, unfortunately, these correlations 
are only valid for non-ionized compounds. Consequently, in order to determine the effective log Po/w value 
at a particular pH, a fast high-throughput method for pKa determination was required. The IS-CE method, 
based on the use of internal standards (IS) and capillary electrophoresis (CE), is a fast and attractive 
alternative to other methods for pKa determination, since it offers multiple advantages compared to them: 
low amounts of test compounds and reagents are needed, high purity is not required, specific interactions 
between test compounds and buffers are corrected, etc. In addition, it allows the determination of a pKa 
value in less than 5 minutes. Both CHI and IS-CE have been combined in order to describe a high 
throughput alternative in the determination of the lipophilicity profiles of bioactive compounds. 
Keywords: lipophilicity, drug discovery, acidity constants, chromatographic hydrophobicity index, CHI, 
internal standard 
 
Introduction 
The drug discovery and development process requires the high-throughput determination of 
physicochemical parameters of drug candidates. Parameters measuring lipophilicity, acidity, solubility or 
protein interaction must be determined in a fast way for a high number of compounds of potential interest 
to select the most promising compounds for further development. 
One of the most important physical properties affecting the biological activity of substances is 
lipophilicity, traditionally expressed as the logarithm of the octanol-water partition coefficient (log Po/w). In 
the common case of drug candidates with acid-base properties, the effective partition rate at a particular 
pH is noted as log Do/w. Although being these the most widely used liphophilicity indexes, experimental 
reference procedures are usually time consuming and require a high purity and a relatively high amount of 
sample. In order to decrease the analysis time and overcome these limitations, instrumental analytical 
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methods have been developed to determine lipophilicity, and the values therefrom obtained in a particular 
lipophilicity scale have been correlated to log Po/w or log Do/w scale.   
About twenty year ago Klára Valkó and Péter Slégel [1] proposed a new hydrophobicity index measured 
by a reversed-phase HPLC method, named ϕ0, defined as the concentration of organic modifier in the 
mobile phase (methanol or acetonitrile) which is required to obtain a retention time (tR) double than the 
dead time (t0). In these conditions, the logarithm of the retention factor equals to zero  
(log k’=log ((tR-t0)/t0)=0) and, therefore, the compound is equally distributed between the mobile and the 
stationary phases. The higher the value, the more hydrophobic is the compound. This index is characteristic 
of a compound and independent of the column dimensions, the mobile phase composition and flow-rate. It 
only depends on the stationary phase, the particular organic modifier employed, the temperature and, for 
acidic or basic compounds, the pH. However, ϕ0 values were experimentally determined in isocratic mode 
using several mobile phases containing low fractions of methanol or acetonitrile, which involved long run 
times for hydrophobic substances. A few years later, Valkó and co-workers [2] proposed a new high-
throughput Chromatographic Hydrophobicity Index (CHI), based on ϕ0 but derived from retention times 
observed in a fast gradient reversed-phase HPLC method. Compounds of previously determined CHI values 
can be used as calibration set, and the retention times of new compounds can be correlated to their 
corresponding CHI values. In that work the C18 column employed was an ODS2-IK5 Inertsil with the 
dimensions of 150 × 4.6 mm, and the gradient program lasted for about 15 min. In a paper published in 
2001 in collaboration with Michael H. Abraham [3] a much shorter column was used, a 50 x 4.6 mm 
Phenomenex Luna C-18(2), and therefore gradient times were reduced to 5 minutes. In addition, 
correlations between CHI and log Po/w were improved by means of hydrogen-bond acidity descriptors, since 
it was found that the major difference between these scales is their sensitivity towards the hydrogen bond 
acidity of the compounds. However, in the case of compounds with acid/base properties, poor correlations 
between CHI and log Do/w have been obtained so far. In 2002 Stephen F. Donovan and Mark C. Pescatore [4] 
used a 20 x 4.2 mm octadecyl–poly(vinyl alcohol cartridge and a fast gradient methanolic elution in order to 
estimate log Po/w from chromatographic data. Due to the pH stability of this polymeric column, the pH of 
the mobile phase could be adjusted to the desired value to ensure the ionizable analyte to be in its neutral 
form.  Nowadays, UHPLC technology presents also an excellent stability of C18 columns over a wide range 
pH, besides higher resolution and sensitivity, and shorter equilibration times within consecutive runs in 
gradient elution.  
Since mostly of the potential drug candidates are acids or bases, log Do/w is a fundamental parameter to 
be determined in the drug discovery process in order to estimate the pharmacokinetics of a compound of 
interest. Especially relevant is the log Do/w at pH 7.4, the physiological value, which indicates the lipophilicity 
of a drug in the blood plasma. As long as this effective partition rate at any particular pH can be estimated 
from the measured log Po/w for the neutral substance and the pKa of the compound, we propose a high-
throughput methodology based on the combination of UHPLC for CHI measurements and CE for pKa 
determination in order to define the log Do/w profile of drug candidates. 
In a series of previous works [5-7], we have proposed a high-throughput method to determine acidity 
constants of weak acids and bases by capillary zone electrophoresis. This method is based on the use of an 
internal standard (IS) of similar nature and acidity constant as the test compound, which is injected into the 
capillary just after the sample compound and analyzed in the same electrophoretic run. This method 
requires only two electrophoretic runs: a first one at a pH where both the test compound and the IS are 
totally ionized, and a second one at another pH at which both are partially ionized. Thus, from the 
mobilities of the compounds at these two pH values and the pKa value of the IS, the pKa of the analyte can 
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be easily calculated [5,8]. Besides its rapidness, the main advantages of this method are the compensation 
of systematic errors due to simultaneous analysis of analyte and IS, and the unnecessity of an accurate pH 
measurement. 
Experimental  
Apparatus  
For UHPLC measurements, a Shimadzu (Kyoto, Japan) Nexera UHPLC system was used. The system was 
equipped with two LC-30AD high-pressure pumps, a DGU-20A5 online degasser, a CTO-10ASvp oven 
thermostatized at 25oC, a SIL-30AC autosampler, a SPD-M20A diode array detector and a CBM-20Alite 
controller. Retention data were obtained from a Waters (Milford, MA, USA) Acquity BEH C18 column, 50 mm 
× 2.1 mm, which allowed the study of basic drugs because of their extended working pH range (up to 12). 
Injected samples were prepared in DMSO at a concentration of 0.5 mg/mL and thus, due to the melting 
point of DMSO (19oC), the autosampler temperature was set at 20oC. Aqueous buffers were, in all cases, 50 
mM ammonium acetate at the desired pH value. Acidic buffers were prepared from glacial acetic acid and 
the pH was adjusted with small volumes of concentrated ammonia (25%), and basic buffers were prepared 
inversely. Medium acidic and basic buffers were obtained by solving the salt and adjusting the pH with 
concentrated ammonia or glacial acetic acid.  
Capillary electrophoresis experiments were performed using a P/ACE MDQ Beckman instrument (Palo 
Alto, CA, USA), equipped with a diode array detector. Capillary was made of fused silica 50 µm I.D., 375 µm 
O.D., 35.2 cm length (25 cm to the detector) and purchased from Composite Metal Services Ltd (Shipley, 
West Yorkshire, UK). The temperature of the capillary was 25.0±0.1oC and the applied voltage during 
separation was 20 kV. IS and analyte samples were sequentially injected at 0.5 psi for 3 s and analyzed in 
the same run. Additional 0.5 psi of hydrodynamic flow during separation was applied. The capillary was 
initially conditioned with 1 M NaOH (2.0 min), water (0.5 min), and running buffer (2.0 min). Between 
replicates with the same buffer the capillary was not rinsed. 20 psi of pressure was applied during rinsing 
processes. Running buffers were prepared at different pH values and 50 mM ionic strength as described 
elsewhere [8]. Injected samples were prepared in methanol/water mixtures at a concentration of 0.1 
mg/mL, containing DMSO as neutral marker. Appropriate IS were selected from the set proposed in 
previous works [8]. All samples and buffers were filtered through a nylon mesh 0.45 µm porous size 
(Whatman, Maidstone, UK) before use. 
pH measurements were performed with a combined Crison (Alella, Spain) 5014 electrode in a Crison 
GLP22 pH meter. The electrode system was standardized with ordinary aqueous buffers of pH 4.01, 7.00 
and 9.21. 
Chemicals 
Acetonitrile HPLC gradient grade was purchased from VWR (West Chester, PA, USA). Water was purified 
by the Milli-Q® plus system from Millipore (Billerica, MA, USA) with a resistivity of 18.2 MΩ cm. The 
chemicals used for buffer preparation were anhydrous sodium acetate (>99.6%) and glacial acetic acid from 
J.T. Baker (Deventer, The Netherlands), 2-(Cyclohexylamino)ethanesulfonic acid (CHES, >99%), and  
3-(cyclohexylamino)-1-propanesulfonic acid (CAPS, >98%) from Sigma (St. Louis, MO, USA),  
2,2-Bis(hydroxymethyl)-2,2’,2’’-nitrilotriethanol (BisTris, >99.9%) from Fluka (Buchs, Switzerland), sodium 
hydroxide, hydrochloric acid and ammonia from Merck (Darmstadt, Germany). Dimethyl sulfoxide (DMSO, 
>99.9%) was purchased from J.T. Baker. The injected compounds were purchased from Merck, Sigma–
Aldrich and Fluka, or obtained from Almirall (Barcelona, Spain), all of them in high purity grade.  
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Results and Discussion 
Measurement of CHIMeCN values by UHPLC 
The HPLC fast gradient method developed by Valkó and co-workers [3] was transferred to our UHPLC 
system taking into consideration the column and particle sizes, the flow rate, the injection volume, and the 
dwell time of the UHPLC instrument. The final UHPLC conditions, together with the original HPLC ones, are 
shown in Table 1. DMSO was used as sample solvent because its ability to solve hydrophobic compounds 
sparingly soluble in MeCN/water mixtures. In the present work MeCN was used as organic modifier as long 
as this solvent allows better correlations between log Po/w and CHI than methanol.  
Several substances covering a wide range of CHIMeCN and log Po/w values were tested as calibration 
standards. Finally, the representative compounds shown in Table 2 were selected. They are mainly 
unionizable substances that can be used at any pH value (acetanilide and phenones), but 4-hydroxybenzyl 
alcohol is a phenol that should be used in its neutral form below pH 8. When using aqueous buffers above 
this pH value, caffeine was used instead of 4-hydroxybenzyl alcohol. A representative chromatogram of the 
calibration set is shown in Figure 1. After plotting the CHIMeCN values against the retention times in the fast 
gradient elution, a quadratic calibration curve is obtained with a typical coefficient of determination (r2) 
higher than 0.998 and a root mean square error (RMSE) lower than 1.5. 
Table 1. Comparison between HPLC and UHPLC conditions to measure CHI values 
 HPLC [3] UHPLC (present work) 
Column C18, 50 x 4.6 mm, 5 μm BEH C18, 50 x 2.1 mm, 1.7 μm 
Flow rate 2.0 mL/min 0.5 mL/min 
Temperature 25
o
C  25
o
C 
Fast gradient program % MeCN % MeCN 
 0.0 min -> 0% 0.0 min -> 0% 
 0.5 min -> 0% 0.4 min -> 0% 
 3.0 min -> 100% 2.5 min -> 100% 
 3.5 min -> 100% 2.9 min -> 100% 
 3.7 min -> 0% 3.1 min -> 0% 
 4.5 min -> 0% 3.8 min -> 0% 
Injection volume and solvent 3 μL - MeCN/aqueous buffer 0.2 μL - DMSO 
Similarly to log Do/w scale, CHI values of acidic or basic compounds depend on the ionization degree. The 
lower the ionization, the higher the CHI value [9,10]. Therefore, acidic substances present the highest CHI 
when aqueous buffers of low pH are used, and consequently basic compounds exhibit the reversed trend. 
On the other hand, non-ionizable analytes show nearly the same CHI values independently of the pH. In the 
present work all studied analytes were injected at three different pH values (3.0, 7.4 and 11.0), and a 
representative collection supporting the above statements is presented in Table 3.  
Table 2. Compounds used as calibration standards. 
Compound CHIMeCN [11] log Po/w [12] pKa [12] 
4-hydroxybenzyl alcohol
a
 18.91 0.25 9.83 
Caffeine
b
 24.45 -0.07 0.60 
Acetanilide 42.38 1.16 - 
Acetophenone 63.26 1.58 - 
Propiophenone 76.93 2.19 - 
Butyrophenone 87.14 2.66 - 
Valerophenone 96.53 3.28 - 
Hexanophenone 105.13 3.79 - 
Heptanophenone 112.79 4.32 - 
a)
Used below pH 8. 
b)
Used above pH 8. 
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Figure 1. Chromatogram of the calibration set after subtraction of the DMSO blank. UHPLC conditions 
according to Table 1, 50 mM ammonium acetate pH 7.4 as aqueous buffer. 
 
Table 3. CHIMeCN values obtained at pH 3.0, 7.4 and 11.0. 
Compounds 
CHIMeCN Analyte 
behavior pH 3.0 pH 7.4 pH 11.0 
Paracetamol 21.2 20.7 -137.2 Acidic 
Theophylline 21.4 20.2 -55.9 Acidic 
Atenolol 19.1 18.6 32.1 Basic 
Colchicine 43.9 43.4 43.8 - 
Salicylic acid 46.0 21.1 -12.5 Acidic 
Benzoic acid 48.0 -64.4 -143.2 Acidic 
Hydrocortisone 50.2 50.0 50.3 - 
Metoprolol 38.1 35.9 61.5 Basic 
Procaine 24.9 30.1 62.9 Basic 
Propranolol 54.2 51.0 80.9 Basic 
Warfarin 82.9 41.8 25.9 Acidic 
Ketoconazole 70.8 83.4 83.9 Basic 
Lidocaine 35.4 77.9 86.4 Basic 
Haloperidol 70.1 66.4 88.9 Basic 
Thymol 90.0 89.9 89.5 Acidic 
Indomethacin 90.7 54.5 37.7 Acidic 
Napththalene 97.6 97.6 97.5 - 
Phenothiazine 98.4 98.4 98.2 - 
Reserpine 82.7 95.6 98.7 Basic 
Anthracene 111.5 111.7 112.3 - 
 
Determination of log Po/w/pKa/log Do/w 
As mentioned in the introduction, Valkó and co-workers proposed an equation to correlate CHIMeCN and 
log Po/w indexes, which involved the Abraham’s solute hydrogen-bond acidity descriptor (A, also noted in 
the original paper as Σα2
H) [3]: 
 o/w MeCN log 0.054 CHI 1.319 A 1.877 86, 0.970, 0.29, 655        P n R s F  (1) 
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Table 4. Validation set used for the determination of log Po/w and log Do/w. 
Behavior Ref. Compound CHIMeCN A 
log Po/w 
(CHI) 
pKa 
(IS-CE) 
log D7.4 
(CHI+IS-CE) 
log D7.4 
(reference) 
Non-ionizable 1 Acetanilide 40.70 0.41 0.86 - 0.86 1.19
a
 
 2 Acetophenone 62.50 0.00 1.50 - 1.50 1.58
a
 
 3 Anthracene 112.30 0.00 4.19 - 4.19 4.49
a
 
 4 Butyrophenone 87.90 0.00 2.87 - 2.87 2.65
a
 
 5 Caffeine 25.90 0.00 -0.48 - -0.48 -0.10
a
 
 6 Colchicine 43.90 0.26 0.83 - 0.83 1.09
a
 
 7 Heptanophenone 112.10 0.00 4.18 - 4.18 4.46
a
 
 8 Hexanophenone 105.20 0.00 3.80 - 3.80 3.69
a
 
 9 Hydrocortisone 50.30 0.73 1.80 - 1.80 1.58
a
 
 10 Naphthalene 97.50 0.00 3.39 - 3.39 3.19
a
 
 11 Phenothiazine 98.40 0.13 3.61 - 3.61 4.11
a
 
 12 Propiophenone 77.20 0.00 2.29 - 2.29 2.24
a
 
 13 Valerophenone 97.00 0.00 3.36 - 3.36 3.40
a
 
Basic 14 Papaverine 66.93 0.00 1.74 6.41 1.69 - 
 15 Reserpine 98.70 0.31 3.86 6.64 3.79 3.89
a
 
 16 2,4-Lutidine 49.35 0.00 0.79 6.81 0.69 - 
 17 Ketoconazole 83.90 0.00 2.65 6.81 2.55 3.42
a
 
 18 Trazodone 76.34 0.00 2.25 6.84 2.14 2.54
b
 
 19 Pilocarpine 20.86 0.00 -0.75 7.08 -0.92 - 
 20 2,4,6-Trimethylpyridine 57.17 0.00 1.21 7.51 0.85 - 
 21 Lidocaine 86.40 0.26 3.13 7.89 2.52 1.61
a
 
 22 Clonidine 51.30 0.42 1.44 8.10 0.67 0.62
b
 
 23 Bupivacaine 101.75 0.26 3.96 8.19 3.11 - 
 24 Quinine 66.42 0.23 2.01 8.45 0.93 - 
 25 Haloperidol 88.90 0.31 3.34 8.56 2.15 2.77
a
 
 26 Procaine 62.90 0.23 1.82 9.08 0.14 0.24
a
 
 27 Propranolol 80.90 0.29 2.88 9.48 0.83 1.23
a
 
 28 Metoprolol 61.50 0.29 1.83 9.53 -0.26 -0.25
a
 
 29 Atenolol 32.10 0.78 0.89 9.67 -1.33 -1.81
a
 
Acidic 30 Paracetamol 21.20 0.91 0.47 9.58 0.46 0.35
a
 
 31 2-Chlorophenol 63.64 0.33 2.00 8.50 1.96 - 
 32 Theophylline 21.40 0.35 -0.27 8.39 -0.31 -0.07
a
 
 33 Methylparaben 52.33 0.66 1.82 8.35 1.78 - 
 34 3,5-Dinitrophenol 85.97 0.83 3.86 8.18 3.80 - 
 35 4-Hydroxybenzaldehyde 38.36 0.66 1.07 7.61 0.86 - 
 36 Phenobarbital 51.84 0.52 1.61 7.53 1.37 1.51
b
 
 37 Vanillin 41.37 0.44 0.94 7.36 0.61 - 
 38 4-Nitrophenol 55.31 0.67 1.99 7.09 1.51 - 
 39 Warfarin 82.90 0.31 3.01 5.17 0.83 0.89
a
 
 40 Benzoic acid 48.00 0.57 1.47 4.22 -1.40 -1.27
a
 
 41 Indomethacin 90.70 0.57 3.77 4.16 0.88 - 
a)
Shake-flask method, ref. [13]. 
b)
Experimental value, ref. [14].  
 
With the aim of validating the UHPLC method proposed, CHIMeCN were measured for several non-
ionizable, acidic and basic compounds in the log Po/w range between -0.07 and 4.45. All analytes were 
injected using aqueous mobile phases of pH 3.0, 7.4, and 11.0, and the highest value was considered for log 
Po/w determination. These 41 compounds are listed in Table 4, together with the CHIMeCN values of neutral 
species determined in the present work, the A solute descriptors obtained from the ACD/Percepta platform 
[15], and the log Po/w determined from CHIMeCN and A according to Eq. (1). There is a good correlation 
between literature log Po/w values (Mlog P values compiled in Bio-Loom database [12]) and the ones 
measured in the present work (slope: 0.99(±0.06), intercept: -0.15(±0.15), r: 0.940, RMSE: 0.45). Basic 
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solutes correlate slightly worse than non-ionizable and acidic compounds. Nevertheless, from the 16 
studied bases only 6 presented deviations from literature values higher than 0.7 log Po/w units. In four of 
those cases the determined log Po/w values were lower than the bibliographic ones (compounds 14, 16, 17, 
and 19 in Table 4), and in two cases (solutes 21 and 29) the reverse trend was shown. 
As previously commented, poor correlations are obtained between log Do/w and CHIMeCN values for 
ionized compounds. However, the effective distribution rate of a drug at a particular pH value can be 
estimated from its acidity constant and the partition coefficients of the neutral and fully ionized species 
[16]. The current state of the art does not allow the direct measurement of the partition coefficient of ions 
but it can be assumed that a typical value is 3.15 units lower than that of the neutral species, according to 
the work published by Donovan and Pescatore [4]. Thus, log Do/w values of monoprotic compounds can be 
calculated from the following expressions at any desired pH value: 
   a apH-p pH-po/w o/w o/wAcidic compound: log =log +( -3.15)·10 - log 1+10K KD P P  (2) 
   a ap -pH p -pHo/w o/w o/wBasic compound:   log =log + ( -3.15)·10 - log 1+10K KD P P  (3) 
Consequently, the measurement of aqueous acidity constants was required in order to estimate log Do/w 
values and the IS-CE fast method was presented as a very appropriate option. This method allows an 
accurate determination of acidity constants, which normally present an excellent match with reference 
values found in literature. In the present work, the correlation between the measured pKa values for some 
of the studied acidic and basic compounds (Table 4) and the ones found in literature was remarkable 
(slope: 1.01(±0.01), intercept: -0.07(±0.09), r: 0.998, RMSE: 0.11).  
Table 4 shows the log Do/w values at pH 7.4 resulting from log Po/w determinations and pKa 
measurements (Eqs. (2-3)) and those obtained from reference methods [13,14]. As shown in Figure 2, there 
is a good agreement between both sets of values, with the only exception of lidocaine, which presented yet 
one of the worst matches in log Po/w determination. 
 
 
Figure 2. Correlation between reference log Do/w values at pH 7.4 (Table 4) and those obtained from log Po/w and 
pKa measurements (Eqs. (2-3)). Linear regression (continuous lines) and the statistics are also shown, together with the 
lines corresponding to ±2·RMSE (dashed lines). 
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Figure 3 shows the log Do/w profile obtained in the present work for vanillin and clonidine, which present 
acidic and basic nature, respectively. For the sake of comparison, the curve calculated by ACD/Labs 
software is also presented, together with their corresponding calculated and measured pKa values. In the 
case of vanillin, the ACD/Labs calculated partition ratio (1.32) is moderately higher than the measured one 
(0.94), whereas both pKa values, estimated and experimental, match very well (7.30 and 7.36, respectively). 
Thus, the ACD/Labs estimated curve shifts up from the experimental one. For clonidine, the ACD/Labs 
calculated log Po/w (2.05) is higher than the CHIMeCN measured one (1.44) by 0.6 units, whereas the pKa 
(7.90) is lower than the IS-CE determined one (8.10). Therefore, the ACD/Labs estimated curve moves up 
and left from the measured one, being the values determined in the present work more accurate according 
to literature (8.05 and 1.43, for pKa and log Po/w, respectively [12]). 
 
 
Figure 3. log Do/w profile for vanillin and clonidine according to Eqs. (2-3) (continuous line) and calculated profile 
using ACD/Labs software (dotted lines), together with their corresponding measured and calculated pKa values.  
 
Conclusions 
In the present work the combination of two high-throughput methods have been proposed in order to 
estimate the log Do/w of an ionizable compound at any desired pH. On the one hand, a fast gradient 
reversed-phase methodology was successfully transferred into UHPLC in order to determine log Po/w from 
chromatographic retention times, based on the formerly developed CHI lipophilicity index. After calibration 
of the system, a single fast-gradient run performed within 4 minutes is enough to determine the CHIMeCN 
value of a compound, and then the value can be transformed into log Po/w lipophilicity scale by means of 
the established equation. In the case of analytes with acid/base properties, runs performed at 3 different 
pH values (3.0, 7.4 and 11) are recommended, and the highest CHIMeCN is selected. On the other hand, the 
IS-CE allows the determination of a pKa value from only two runs, lasting less than 5 minutes (about 2 min 
each). Finally, from both the log Po/w of the neutral species (UHPLC-CHI procedure) and the pKa value (IS-CE 
method), the effective distribution rate log Do/w can be estimated at any particular pH value. 
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